Harbor國際股票主動型ETF EPIN 深 滬
等待開盤 02-20 09:30:00 美东时间
25.1099
-0.055
-0.22%
華盛通- 最 高25.1099
- 今 開--
- 成交量 0股
- 最 低 25.1099
- 昨 收 25.1646
- 總市值 690.52万
- 52周最高 25.2203
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 19.7442
- 委 比 0.00%
- 總股本 27.50万
- 歷史最高 25.2203
- 量 比 0
- 振 幅 0.00%
- 歷史最低 19.7442
- 每 手 1
- 風險率 1.41%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BRIEF-Fresenius Kabi Oncology Ltd Co And Phlow Corp Announce End-To-End, U.S. Manufacturing Collaboration For Epinephrine Injection
BRIEF-Fresenius Kabi Oncology Ltd Co And Phlow Corp Announce End-To-End, U.S. Manufacturing Collaboration For Epinephrine Injection Feb 9 (Reuters) - Fresenius Kabi Oncology Ltd FRES.M3 : FRESENIUS KABI ONCOLOGY LTD: CO AND PHLOW CORP ANNOUNCE END-TO-END, U.S. MANUFACTURING COLLABORATION FOR EPINEPH
02-09 22:56
BRIEF-Fresenius Says Fresenius Kabi Enters Partnership With U.S. Phlow To Establish Supply Chain For Epinephrine
BRIEF-Fresenius Says Fresenius Kabi Enters Partnership With U.S. Phlow To Establish Supply Chain For Epinephrine Feb 9 (Reuters) - FRESENIUS SE & CO KGAA FREG.DE : FRESENIUS KABI ENTERS PARTNERSHIP WITH U.S. MANUFACTURER PHLOW CORP. TO ESTABLISH A DOMESTIC, END TO END SUPPLY CHAIN FOR EPINEPHRINE IN
02-09 22:30
BRIEF-Modon Holding Forms JV With Related Companies And Panepinto Properties To Deliver Harborside 4
Dec 22 (Reuters) - Modon Holding PSC MODON.AD: MODON HOLDING - FORMS JV WITH RELATED COMPANIES AND PANEPINTO PROPERTIES TO DELIVER HARBORSIDE 4 MODON HOLDING - MODON ACQUIRES A MAJORITY EQUITY STAKE I...
2025-12-22 12:10
BRIEF-Amneal Receives U.S. FDA Approval For Epinephrine Injection
Dec 9 (Reuters) - Amneal Pharmaceuticals Inc AMRX.O: AMNEAL RECEIVES U.S. FDA APPROVAL FOR EPINEPHRINE INJECTION IN SINGLE- AND MULTI-DOSE VIALS FOR U.S. HOSPITALS Source text: ID:nGNXhc7Lv Further co...
2025-12-10 05:04
BRIEF-ARS Pharmaceuticals Receives Favorable Decision From European Patent Office On Patent Related To Neffy® (Epinephrine Nasal Spray)
Oct 8 (Reuters) - ARS Pharmaceuticals Inc SPRY.O: ARS PHARMACEUTICALS RECEIVES FAVORABLE DECISION FROM EUROPEAN PATENT OFFICE ON PATENT RELATED TO NEFFY® (EPINEPHRINE NASAL SPRAY) ARS PHARMACEUTICALS ...
2025-10-08 20:10
BRIEF-Robo.ai Invests In DePIN Project Arkreen, Exploring Web3 Technology And Machine Economy Integration
Sept 18 (Reuters) - Robo.ai Inc AIIO.O: ROBO.AI INVESTS IN DEPIN PROJECT ARKREEN, EXPLORING WEB3 TECHNOLOGY AND MACHINE ECONOMY INTEGRATION Source text: ID:nPn3SwTZ3a Further company coverage: AIIO.O ...
2025-09-18 21:20
BRIEF-Abcourt Announces Increase To Loan Financing With Nebari
Sept 10 (Reuters) - Abcourt Mines Inc ABI.V: ABCOURT ANNOUNCES INCREASE TO LOAN FINANCING WITH NEBARI TO ACCELERATE SLEEPING GIANT MINE DEVELOPMENT ABCOURT MINES INC - SECURES $2 MILLION UPSIZED LOAN ...
2025-09-10 23:23
BRIEF-Aquestive Therapeutics Announces $75M Strategic Funding Agreement with RTW
Aug 14 (Reuters) - Aquestive Therapeutics Inc AQST.O: AQUESTIVE THERAPEUTICS ANNOUNCES $75M STRATEGIC FUNDING AGREEMENT WITH RTW TO SUPPORT THE POTENTIAL LAUNCH OF ANAPHYLM™ (EPINEPHRINE) SUBLINGUAL F...
2025-08-14 18:27
BRIEF-Gland Pharma Receives Approval From USFDA For Norepinephrine Bitartrate In 5% Dextrose Injection
Aug 12 (Reuters) - Gland Pharma Ltd GLAD.NS: RECEIVES APPROVAL FROM USFDA FOR NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION Further company coverage: GLAD.NS ((Reuters.Briefs@thomsonreuters.com;;...
2025-08-12 15:37
Amphastar Pharma Q2 revenue beats estimates
Overview Amphastar Pharma Q2 revenue of $174.4 mln beats analyst expectations, per LSEG data Adjusted EPS of $0.85 surpasses consensus, driven by strong BAQSIMI sales Co announces major infrastructure...
2025-08-08 04:42
